HEPATOID ADENOCARCINOMA OF STOMACH
Clinical trials for HEPATOID ADENOCARCINOMA OF STOMACH explained in plain language.
Never miss a new study
Get alerted when new HEPATOID ADENOCARCINOMA OF STOMACH trials appear
Sign up with your email to follow new studies for HEPATOID ADENOCARCINOMA OF STOMACH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare stomach cancer in early trial
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs and an immunotherapy drug for a rare type of stomach cancer called hepatoid adenocarcinoma. The treatment is given before and after surgery to see if it can shrink the tumor and improve outcomes. The trial involves 30 participa…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New drug cocktail shows promise for rare stomach cancer
Disease control Recruiting nowThis study tests a combination of three drugs (RC48, chemotherapy, and an immunotherapy) given before and after surgery for a rare stomach cancer called hepatoid adenocarcinoma. The goal is to see if this approach can completely eliminate the tumor before surgery and prevent it f…
Matched conditions: HEPATOID ADENOCARCINOMA OF STOMACH
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 08, 2026 12:03 UTC